Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sleep Aid Supplement Market Waking Up To Meet Diverse Consumer Needs

This article was originally published in The Tan Sheet

Executive Summary

As consumers realize melatonin is not a cure-all for sleep challenges, they will seek other supplements, notably in the area of adaptogen herbs, says Nature’s Way research executive Jeremy Appleton.

You may also be interested in...



On Appeal To Advertising Experts, P&G Gets Nod For ‘#1’ Claim With Brand Qualifier On Oral-B Picks

National Advertising Review Board says P&G’s #1” claim in a shield-shaped logo on Oral-B Precision Clean Interdental Picks package fronts “is adequately connected to the explanatory information," which states “from the makers of the #1 dentist recommended floss brand.”

VGH Solutions Feels Pain In US Review For Basing OTC Device Ad Claims On Canada’s Approval

NAD advises VGH Solutions to pull pain relief claims and statements that am OTC device with FDA 510(k) clearance treats conditions including neuropathy. The firm offered studies and a Health Canada statement listing indications for the device to support claims not part of the US approved indication.

NAD Offers Complex And Fast Tracks: Not All Advertising Claim Reviews Are Alike

NAD will assign three attorneys at the beginning of each Complex Track review instead of one, director Laura Brett said in a recent interview. The industry self-regulation group also recently launched its Fast-Track program for more simple ad claim challenges that rarely have been made.

Topics

UsernamePublicRestriction

Register

ID1132028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel